EyeBio vs REGENXBIO
EyeBio
Developing a new generation of therapies to protect, restore, and improve vision
109 employees · est. 2021 · London, United Kingdom
REGENXBIO
Seeking to improve lives through the curative potential of gene therapy
389 employees · est. 2008 · Rockville, United States
REGENXBIO is the older company (2021 vs 2008); REGENXBIO is the larger of the two.
Side-by-Side Comparison
| Metric | EyeBio | REGENXBIO |
|---|---|---|
| Founded | ||
| Founded | 2021 | 2008 older |
| Headquarters | ||
| Headquarters | London, United Kingdom | Rockville, United States |
| Employees | ||
| Employees | 109 | 389 larger |
| Industry | ||
| Industry | Biotechnology | Biopharma, Biotechnology, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Acquired | IPO |
| Total Funding | ||
| Total Funding | $3.13B | $1.58B |
| Funding Rounds | ||
| Funding Rounds | 4 | 17 |
| Services | ||
| Services | Research and Development, Therapeutic Modalities, Clinical Trials, Patient Support Programs, Business Development and Licensing, Philanthropy and Medical Outreach | Developing Gene Therapy Candidates, Clinical Trials, In-house Manufacturing, Research and Development |
| Target Customers | ||
| Target Customers | Patients with Retinal Diseases, Healthcare Professionals, Research Scientists, Pharmaceutical Distributors, Investors, Healthcare Institutions | Patients with Retinal Diseases, Patients with Genetic Disorders, Healthcare Providers, Pharmaceutical Partners |
| Taxonomy | ||
| Taxonomy | OphthalmologyBiopharmaceuticalsVision TherapyEye DiseasesAge-related Macular DegenerationAnti-vascular Endothelial Growth Factor +8 | Gene TherapyAAV TherapeuticsBiopharmaceuticalsRetinal DiseasesRare DiseasesAAV Vectors +8 |
| Website | ||
| Website | eyebiotech.com | regenxbio.com |
About EyeBio
EyeBio, founded in 2021, is an innovative biotechnology company based in the United Kingdom, specializing in ophthalmology. The company's driving mission, encapsulated in its slogan—"Developing a new generation of therapies to protect, restore, and improve vision"—focuses on addressing the unmet nee...
About REGENXBIO
REGENXBIO, founded in 2008, is a clinical-stage biotechnology company based in the United States known for its pioneering work in AAV Therapeutics, a promising class of gene therapy medicines. The company is actively advancing a robust pipeline targeting retinal and rare diseases with products like...
Also comparing in this category
Comparing more than these two?
Get EyeBio, REGENXBIO and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does EyeBio compare?
A PDF of EyeBio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare EyeBio with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at EyeBio on 28 Jan 2026, and REGENXBIO on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
